BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24726620)

  • 1. Risk factors for human papillomavirus persistence among women undergoing cold-knife conization for treatment of high-grade cervical intraepithelial neoplasia.
    Baser E; Ozgu E; Erkilinc S; Togrul C; Caglar M; Gungor T
    Int J Gynaecol Obstet; 2014 Jun; 125(3):275-8. PubMed ID: 24726620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion.
    Zang L; Hu Y
    Arch Gynecol Obstet; 2021 Dec; 304(6):1409-1416. PubMed ID: 34482445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis.
    Cassani C; Dominoni M; Pasquali MF; Gardella B; Spinillo A
    Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1028-1035. PubMed ID: 38477097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study.
    Dvořák V; Petráš M; Dvořák V; Lomozová D; Dlouhý P; Králová Lesná I; Pilka R
    Hum Vaccin Immunother; 2024 Dec; 20(1):2343552. PubMed ID: 38723789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome.
    Hartman CA; Bragança JF; Gurgel MSC; Zeferino LC; Andrade LALA; Teixeira JC
    PLoS One; 2021; 16(7):e0253998. PubMed ID: 34283862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV persistence after cervical surgical excision of high-grade cervical lesions.
    Bogani G; Sopracordevole F; Ciavattini A; Vizza E; Vercellini P; Ghezzi F; Scambia G; Di Donato V; Giannini A; Raspagliesi F
    Cancer Cytopathol; 2024 May; 132(5):268-269. PubMed ID: 37747763
    [No Abstract]   [Full Text] [Related]  

  • 8. High-risk HPV positivity is a long-term risk factor for recurrence after cervical excision procedure in women living with HIV.
    Agarossi A; Delli Carpini G; Sopracordevole F; Serri M; Giannella L; Gardella B; Maestri M; Del Fabro A; Sansone M; Fallani MG; Pieralli A; Fasolo MM; Mazzali C; Ciavattini A
    Int J Gynaecol Obstet; 2021 Dec; 155(3):442-449. PubMed ID: 33721323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022.
    Rykkelid M; Wennberg HM; Richardsen E; Sørbye SW
    Pathogens; 2024 May; 13(5):. PubMed ID: 38787233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nursing Care of Postoperative Supplementary Surgery for Patients with Positive or High-level CIN after Conization Using CINIII Cold Knife.
    He J; Wu Y; Su Y
    Altern Ther Health Med; 2024 May; ():. PubMed ID: 38814609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation.
    Liu X; Yu B; Gao F; Jing P; Zhang P; Zheng G; Zhang X
    Front Immunol; 2023; 14():1259723. PubMed ID: 38235142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic outcome of cervical laser ablation using a holmium yttrium-aluminum-garnet (Ho:YAG) laser for the treatment of cervical intraepithelial neoplasia: A single-center retrospective study.
    Suzuki W; Ietani K; Makabe T; Oki S; Ohno A; Mikami Y; Yamashita H
    Gynecol Oncol Rep; 2024 Jun; 53():101405. PubMed ID: 38757116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the safety and efficacy of HIFU in the treatment of VaIN.
    Wu S; Li X; Xu D; Ye M
    Int J Hyperthermia; 2024; 41(1):2346216. PubMed ID: 38735651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod Is Effective in Reducing Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.
    Hamar B; Teutsch B; Hoffmann E; Hegyi P; Harnos A; Nyirády P; Hunka Z; Ács N; Bánhidy F; Melczer Z
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of persistent HPV infection after treatment for high-grade squamous intraepithelial lesion.
    So KA; Lee IH; Kim TJ; Lee KH
    Arch Gynecol Obstet; 2019 Jan; 299(1):223-227. PubMed ID: 30341502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Weldegebreal F; Worku T
    Cancer Control; 2019; 26(1):1073274819845872. PubMed ID: 31043067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization.
    Chen JY; Wang ZL; Wang ZY; Yang XS
    Medicine (Baltimore); 2018 Oct; 97(41):e12792. PubMed ID: 30313104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA.
    Vidal AC; Smith JS; Valea F; Bentley R; Gradison M; Yarnall KS; Ford A; Overcash F; Grant K; Murphy SK; Hoyo C
    Cancer Causes Control; 2014 Aug; 25(8):1055-62. PubMed ID: 24928693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia.
    Rizzuto I; Nalam M; Jiang J; Linder A; Rufford B
    Int J Gynaecol Obstet; 2018 May; 141(2):240-244. PubMed ID: 29250779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.